| Dr Jonna Wray Cubin, MD | |
|
1233 E 2nd St, Casper, WY 82601-2926 | |
| (307) 333-6910 | |
| Not Available |
| Full Name | Dr Jonna Wray Cubin |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 21 Years |
| Location | 1233 E 2nd St, Casper, Wyoming |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013043835 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 7914A (Wyoming) | Secondary |
| 207P00000X | Emergency Medicine | 7914A (Wyoming) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wyoming Medical Center | Casper, WY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Medical Physicians Pc | 4385771757 | 14 |
News Archive
A new study at Columbia University suggests that giving mothers plain facts about the health risks of consuming sugary drinks during pregnancy and early childhood may offer a new strategy to reduce childhood obesity.
Age-related decline in the efficacy of DNA repair may underlie reproductive aging, say researchers.
After receiving acupuncture treatment three days a week during the course of radiation treatment, head and neck cancer patients experienced less dry mouth, according to study results from researchers at The University of Texas MD Anderson Cancer Center.
AVANIR Pharmaceuticals, Inc. today announced long-term efficacy data from the 12-week double-blind phase and the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating Zenvia™ (dextromethorphan/quinidine) in the treatment of pseudobulbar affect in patients with underlying multiple sclerosis or amyotrophic lateral sclerosis.
› Verified 5 days ago
| Entity Name | Emergency Medical Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720310709 PECOS PAC ID: 4385771757 Enrollment ID: O20100416000684 |
News Archive
A new study at Columbia University suggests that giving mothers plain facts about the health risks of consuming sugary drinks during pregnancy and early childhood may offer a new strategy to reduce childhood obesity.
Age-related decline in the efficacy of DNA repair may underlie reproductive aging, say researchers.
After receiving acupuncture treatment three days a week during the course of radiation treatment, head and neck cancer patients experienced less dry mouth, according to study results from researchers at The University of Texas MD Anderson Cancer Center.
AVANIR Pharmaceuticals, Inc. today announced long-term efficacy data from the 12-week double-blind phase and the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating Zenvia™ (dextromethorphan/quinidine) in the treatment of pseudobulbar affect in patients with underlying multiple sclerosis or amyotrophic lateral sclerosis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonna Wray Cubin, MD Po Box 50770, Casper, WY 82605-0770 Ph: (307) 333-6910 | Dr Jonna Wray Cubin, MD 1233 E 2nd St, Casper, WY 82601-2926 Ph: (307) 333-6910 |
News Archive
A new study at Columbia University suggests that giving mothers plain facts about the health risks of consuming sugary drinks during pregnancy and early childhood may offer a new strategy to reduce childhood obesity.
Age-related decline in the efficacy of DNA repair may underlie reproductive aging, say researchers.
After receiving acupuncture treatment three days a week during the course of radiation treatment, head and neck cancer patients experienced less dry mouth, according to study results from researchers at The University of Texas MD Anderson Cancer Center.
AVANIR Pharmaceuticals, Inc. today announced long-term efficacy data from the 12-week double-blind phase and the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating Zenvia™ (dextromethorphan/quinidine) in the treatment of pseudobulbar affect in patients with underlying multiple sclerosis or amyotrophic lateral sclerosis.
› Verified 5 days ago
Dr. Jerry Robert Realing, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1233 E 2nd St, Casper, WY 82601 Phone: 307-333-6910 Fax: 307-333-6912 | |
Dr. Ryan Scott Benson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1233 E 2nd St, Casper, WY 82601 Phone: 307-333-6910 Fax: 307-333-6912 | |
Makenzie Volker Bartsch, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2510 E 15th St Ste 12, Casper, WY 82609 Phone: 307-333-6910 Fax: 307-333-6912 | |
Dr. Travis Paul Washut, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1233 E 2nd St, Casper, WY 82601 Phone: 307-333-6910 Fax: 307-333-6912 | |
Joel M Pull, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4450 E 24th St, Casper, WY 82609 Phone: 307-254-2472 | |
Dr. David B Tarullo, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1233 E 2nd St, Casper, WY 82601 Phone: 307-577-2222 | |
Michael R Bruno, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1233 E 2nd St, Casper, WY 82601 Phone: 307-333-6910 Fax: 307-333-6912 |